Delivery of oligonucleotide‐based therapeutics: challenges and opportunities

Delivery of oligonucleotide‐based therapeutics: challenges and opportunities

Abstract Nucleic acid‐based therapeutics that regulate gene expression have been developed towards clinical use at a steady pace for several decades, but in recent years the field has been accelerating. To date, there are 11 marketed products based on antisense oligonucleotides, aptamers and small i...

Full description

Bibliographic Details
Main Authors: Suzan M Hammond, Annemieke Aartsma‐Rus, Sandra Alves, Sven E Borgos, Ronald A M Buijsen, Rob W J Collin, Giuseppina Covello, Michela A Denti, Lourdes R Desviat, Lucía Echevarría, Camilla Foged, Gisela Gaina, Alejandro Garanto, Aurelie T Goyenvalle, Magdalena Guzowska, Irina Holodnuka, David R Jones, Sabine Krause, Taavi Lehto, Marisol Montolio, Willeke Van Roon‐Mom, Virginia Arechavala‐Gomeza
Format: Article
Language:English
Published: Wiley 2021-04-01
Series:EMBO Molecular Medicine
Subjects:
delivery
oligonucleotides
preclinical models
RNA therapeutics
safety
Online Access:https://doi.org/10.15252/emmm.202013243

Internet

https://doi.org/10.15252/emmm.202013243

Similar Items